Title : Use of proteasome inhibition in the treatment of lung cancer.

Pub. Date : 2004 Dec

PMID : 15638966






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib targets pathways relevant to tumor progression and therapy resistance and can directly modulate expression of cyclins, p27kip1, p53, nuclear factor-kB, Bcl-2, and Bax. Bortezomib tumor protein p53 Homo sapiens